The selective ROCK2 inhibitor KD025 reduces IL-17 secretion in human peripheral blood mononuclear cells independent of IL-1 and IL-6-Reference-Cited by-同舟云学术

The selective ROCK2 inhibitor KD025 reduces IL-17 secretion in human peripheral blood mononuclear cells independent of IL-1 and IL-6

Published:2018-09-21 Issue:10 Volume:48 Page:1679-1686
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Tengesdal Isak W.¹²^ORCID,Kitzenberg David¹,Li Suzhao¹,Nyuydzefe Melanie S.³,Chen Wei³,Weiss Jonathan M.³,Zhang Jingya³,Waksal Samuel D.³,Zanin-Zhorov Alexandra³,Dinarello Charles A.¹²

Affiliation:

1. Dept. Medicine; University of Colorado Denver; Aurora CO USA

2. Department of Internal Medicine; Radboud University Medical Center; Nijmegen The Netherlands

3. Kadmon Corporation; LLC; New York NY USA

Funder

Interleukin Foundation for Medical Research

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201847652/fullpdf

Reference37 articles.

1. IL-17 and Th17 Cells;Korn;Annu. Rev. Immunol.,2009

2. Mechanisms regulating skin immunity and inflammation;Pasparakis;Nat. Rev. Immunol.,2014

3. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses;Lowes;Trends Immunol.,2013

4. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis;Mudigonda;Dermatol. Online J.,2012

5. Pathogenesis and therapy of psoriasis;Lowes;Nature,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selectivity matters: selective ROCK2 inhibitor ameliorates established liver fibrosis via targeting inflammation, fibrosis, and metabolism;Communications Biology;2023-11-18

2. Unraveling the rationale and conducting a comprehensive assessment of KD025 (Belumosudil) as a candidate drug for inhibiting adipogenic differentiation—a systematic review;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-15

3. Identification of immune‐associated signatures and potential therapeutic targets for pulmonary arterial hypertension;Journal of Cellular and Molecular Medicine;2023-09-27

4. Synthetic Approaches to the New Drugs Approved During 2021;Journal of Medicinal Chemistry;2023-08-01

5. A critical review of belumosudil in adult and pediatric patients with chronic graft-versus-host disease;Expert Review of Clinical Immunology;2022-11-30